PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
GTHX vs. XBI
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between GTHX and XBI is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

GTHX vs. XBI

Last updated May 31, 2025

Compare and contrast key facts about G1 Therapeutics, Inc. (GTHX) and SPDR S&P Biotech ETF (XBI).

XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006.

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GTHX or XBI.

Performance

GTHX vs. XBI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in G1 Therapeutics, Inc. (GTHX) and SPDR S&P Biotech ETF (XBI). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Returns By Period

GTHX

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

3Y*

N/A

5Y*

N/A

10Y*

N/A

XBI

YTD

-12.06%

1M

-4.53%

6M

-20.50%

1Y

-10.85%

3Y*

4.87%

5Y*

-5.15%

10Y*

0.11%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

G1 Therapeutics, Inc.

SPDR S&P Biotech ETF

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

GTHX vs. XBI — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
GTHX
The Risk-Adjusted Performance Rank of GTHX is 9494
Overall Rank
The Sharpe Ratio Rank of GTHX is 9494
Sharpe Ratio Rank
The Sortino Ratio Rank of GTHX is 8989
Sortino Ratio Rank
The Omega Ratio Rank of GTHX is 9494
Omega Ratio Rank
The Calmar Ratio Rank of GTHX is 9696
Calmar Ratio Rank
The Martin Ratio Rank of GTHX is 9494
Martin Ratio Rank
XBI
The Risk-Adjusted Performance Rank of XBI is 66
Overall Rank
The Sharpe Ratio Rank of XBI is 66
Sharpe Ratio Rank
The Sortino Ratio Rank of XBI is 66
Sortino Ratio Rank
The Omega Ratio Rank of XBI is 66
Omega Ratio Rank
The Calmar Ratio Rank of XBI is 88
Calmar Ratio Rank
The Martin Ratio Rank of XBI is 66
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

GTHX vs. XBI - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for G1 Therapeutics, Inc. (GTHX) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

GTHX vs. XBI - Dividend Comparison

GTHX has not paid dividends to shareholders, while XBI's dividend yield for the trailing twelve months is around 0.17%.

TTM20242023202220212020201920182017201620152014
GTHX
G1 Therapeutics, Inc.		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
XBI
SPDR S&P Biotech ETF		0.17%0.15%0.02%0.00%0.04%0.20%0.00%0.28%0.24%0.26%0.61%1.07%

Drawdowns

GTHX vs. XBI - Drawdown Comparison

Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

GTHX vs. XBI - Volatility Comparison

Loading data...